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Abstract
Background: Recent years have seen a significant increase in the availability of smartphone apps for mental health problems.
Despite their proliferation, few apps have been specifically developed for young people, and almost none have been subject to
any form of evaluation.
Objective: This study aimed to undertake a preliminary evaluation of a smartphone app (BlueIce), coproduced with young
people and designed to help young people manage distress and urges to self-harm. We aimed to assess the acceptability, safety,
and use of BlueIce and to explore the effects on the primary outcome of self-harm and the secondary outcomes of psychological
functioning.
Methods: We undertook an open trial where we recruited young people aged 12 to 17 years attending specialist child and
adolescent mental health services (CAMHS) who were currently self-harming or had a history of self-harm. Eligible participants
were assessed at baseline and then given BlueIce. They were assessed 2 weeks later (post familiarization) and again at 12 weeks
(post use). A behavior-screening questionnaire (Strengths and Difficulties Questionnaire) was completed along with standardized
measures of depression (Mood and Feelings Questionnaire or MFQ) and anxiety (Revised Child Anxiety and Depression Scale
or RCADS), taking into account self-reports of self-harm, app helpfulness, and safety.
Results: All core CAMHS professional groups referred at least 1 young person. Out of 40 young people recruited, 37 (93%)
elected to use BlueIce after familiarization, with 29 out of 33 (88%) wanting to keep it at the end of the study. No young person
called the emergency numbers during the 12-week trial, and no one was withdrawn by his or her clinician due to increased risk
of suicide. Almost three-quarters (73%) of those who had recently self-harmed reported reductions in self-harm after using BlueIce
for 12 weeks. There was a statistically significant mean difference of 4.91 (t31=2.11; P=.04; 95% CI 0.17-9.64) on postuse
symptoms of depression (MFQ) and 13.53 on symptoms of anxiety (RCADS) (t30=3.76; P=.001; 95% CI 6.17-20.90), which was
evident across all anxiety subscales. Ratings of app acceptability and usefulness were high.
Conclusions: Our study has a number of methodological limitations, particularly the absence of a comparison group and a
prospective way of assessing self-harm. Nonetheless, our findings are encouraging and suggest that BlueIce, used alongside a
traditional CAMHS face-to-face intervention, can help young people manage their emotional distress and urges to self-harm.
(JMIR Mhealth Uhealth 2018;6(1):e32)   doi:10.2196/mhealth.8917
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Introduction
Self-Harm
Self-harm has been defined as the intentional self-poisoning or
self-injury, irrespective of the type of motive or the extent of
suicidal intent [1]. Self-harm in young people aged up to 18
years is a major public health problem [2] with community
surveys reporting that up to 20% of young people will self-harm
by the age of 18 years [3-7]. Figures from hospital episode
statistics show that in 2014-2015, 16,000 young people attended
accident and emergency department (A&E) in England
following self-poisoning [8], whereas a survey of National
Health Service (NHS) trusts found that 19,000 adolescents were
hospitalized in England and Wales following self-harm in 2016
[9].This statistic underestimates the scale of the problem because
the majority of self-harm remains hidden with comparatively
few episodes being treated in a hospital [10].
Although self-harm in young people is common, few
intervention studies have been reported [11]. Evidence that is
available suggests that therapeutic assessment, mentalization,
dialectical behavioral therapy (DBT), and cognitive-behavioral
therapy (CBT) may be promising and warrant further evaluation
[11]. Key challenges for future research are the development
and assessment of innovative interventions that are acceptable
to young people, which reduce the risk of self-harm and enhance
meaningful engagement with health services [12].
Digital Health
In the United Kingdom, the NHS is being encouraged to harness
digital technology to enhance and support psychological health
[13]. Digital health technology may be particularly attractive
for young people who are very familiar with and frequent users
of digital media. It offers an accessible way of supporting health
services because nearly all young people aged 12-15 years have
Internet access and 90% own a smartphone [14].
One form of digital technology, smartphone apps, has seen
particular growth [15]. However, few apps have been
specifically developed for young people with mental health
problems, almost none have been subject to any form of
evaluation, and none have been developed specifically for
children who self-harm [16]. It is essential that smartphone apps
for adolescents are subject to research evaluation [16] and
codesigned with people who have lived experience [11].
We developed and coproduced a smartphone app (BlueIce) with
young people with lived experience of self-harm. BlueIce is to
be used in conjunction with face-to-face interventions and
provides a personalized toolbox of strategies founded on
evidence-based approaches that can be accessed at any time.
The aim of this study was to explore the safety, acceptability,
feasibility, and usability of a novel smartphone app, BlueIce,
developed specifically for young people who self-harm. We
will explore the effect on self-harm (primary outcome) and also
on psychological functioning (secondary outcome).
Methods
BlueIce
We coproduced a smartphone app, BlueIce, with young people
with a lived experience of self-harm. We adopted a
user-centered, agile development process to create, refine, and
evaluate BlueIce. This was a tripartite process whereby the
product users (young people and clinical staff), academics, and
app developers worked together. This process aimed to
maximize the acceptability and use of the app by our target
group and ensured that the content reflected current evidence
and best clinical practice. Informed by the available evidence,
BlueIce provides a personalized toolbox of strategies based on
CBT and DBT that can be accessed 24/7 [1,11]. It includes a
mood diary, menu of personalized mood-lifting activities, and
automatic routing through safety checks to delay or prevent
self-harm. Mood-lifting activities are designed to improve mood
and include a personalized music library of uplifting music,
photo library of positive memories, physical activities,
mood-changing activities, audio-taped relaxation and
mindfulness exercises, identification and challenging of negative
thoughts, a contact list of key people to call or text, and distress
tolerance activities (informed by DBT). After using the
mood-lifting section, the young person is asked to rerate his or
her mood, and if the urge to self-harm has not reduced, that
young person is automatically routed to emergency numbers
(nominated contact, Childline, 111) that he or she can call.
BlueIce is for young people aged 12-17 years and is designed
as an adjunct to face-to-face therapy. It is available for use on
Apple and Android devices. It has met the minimum standards
required for NHS-accredited apps [17]. BlueIce is password
protected and all data are stored locally on the device. BlueIce
is a prescribed app and is available via license to child and
adolescent mental health services (CAMHS). Information about
the app is available at the webpage )[18].
Study Design
This is a phase 1 open uncontrolled trial. A detailed summary
of the methodology is provided in the study protocol [19].
Setting
Young people were recruited from specialist CAMHS outpatient
clinics provided by Oxford Health NHS Foundation Trust. The
trust provides CAMHS across Bath and North East Somerset,
Buckinghamshire, Oxfordshire, Swindon, and Wiltshire in the
United Kingdom.
Participants
Eligible young people aged 12-17 years who were currently
self-harming or had a history of self-harm were included. Young
people were excluded if first, they were seriously contemplating
or planning a suicide attempt. Given that we do not know
whether BlueIce will have any unintentional adverse effects, it
would not be safe to test it with a high-risk group who were
actively suicidal. Second, young people were excluded if they
were diagnosed with psychosis or had a significant learning
disability, which might impede their ability to use the app. Third,
those who had been subject to abuse within the last 6 months
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or were the subject of a safeguarding investigation were
excluded. Finally, BlueIce is only available in English, and we
therefore excluded those who were not proficient in English.
Recruitment and Consent
Eligible participants were identified by their CAMHS clinician
and provided with a project information sheet. Interested young
people, and their parents if they are under 16 years, met with a
researcher to get familiarized with the project. Signed consent
was obtained from young people above the age of 16 years, and
signed parent consent and child assent from those under 16
years. The project was reviewed and approved by the South
West—Exeter Research Ethics Committee (16/SW/0018).
Consenting participants were provided with BlueIce but
continued to attend face-to-face meetings with their CAMHS
clinician. As is usual practice, the CAMHS clinician was
responsible for reviewing risk and implementing any risk plans
required to keep the young person safe.
Assessments
Standardized questionnaires were completed at baseline, post
familiarization (2 weeks after using BlueIce), and post use (12
weeks).
Depression
Symptoms of depression were assessed by the Mood and
Feelings Questionnaire (MFQ), a self-report questionnaire for
depression [20]. The MFQ consists of 33 items, which the young
person rates as either true (scores 2), sometimes true (scores 1)
or not true (scores 0). The MFQ has high criterion validity and
correlates well with other measures of depression [21]. A total
score of 27 and above is associated with major depression, 20
with mild depression, and 16 with no mood disorder [21-23].
Anxiety
Symptoms of anxiety were assessed by the Revised Child
Anxiety and Depression Scale (RCADS) [24]. RCADS is a
47-item questionnaire with items corresponding to Diagnostic
and Statistical Manual 4th Edition (DSM-IV) criteria for anxiety
in the areas of social phobia, separation anxiety, obsessive
compulsive disorder, panic disorder, and generalized anxiety
disorder and also for other major depressive disorders. Each
item is rated on a 4-point Likert scale of frequency ranging from
never (0) to always (3), and items are then summed to produce
subscale and total anxiety scores. There are age- and
gender-related norms for identifying clinically significant scores
(total score≥64-80) [24]. If the young person was under 16 years,
his or her parents were also asked to complete this measure.
Behavior
The Strengths and Difficulties Questionnaire (SDQ) is a brief,
widely used behavioral screening questionnaire [25]. The SDQ
consists of 25 items that assess emotional symptoms, conduct
problems, hyperactivity and/or inattention, peer relationship
problems, and prosocial behavior. Participants also rate overall
distress and social impact of their behavior on home life,
friendships, classroom learning, and leisure activities. Parents
also completed this measure if the young person was under 16
years.
Safety
At post familiarization, young people were asked whether
BlueIce makes them feel like harming themselves even more,
whether they felt able to use BlueIce if they had thoughts of
self-harm, and whether they thought BlueIce would help them
stop self-harming. Participants rated their responses on a 5-point
Likert scale ranging from 1 (definite no) to 5 (definitely).
Acceptability
At post use, young people used a 10-point Likert scale to rate
the ease of use, helpfulness, and whether they would recommend
BlueIce to a friend.
Self-Harm
Information on baseline levels of self-harm was obtained from
clinical records spanning the 4 weeks before using BlueIce.
Self-harm during the trial was assessed via self-report during
the interview at baseline and 12 weeks. By estimating the
number of self-harm acts that would have occurred if
participants continued to self-harm at the same rate through the
12-week trial, we calculated the number of self-harm acts
prevented for the young people who (1) stopped self-harming
at post use and (2) continued to self-harm at post use but at a
reduced rate.
Results
Demographics and Baseline Assessments
Between May and October 2016, 37 different clinicians from
8 CAMHS teams referred 54 young people. All core
professionals that constitute CAMHS, that is, child psychiatrists,
clinical psychologists, family therapists, child psychotherapists,
occupational therapists, and community psychiatric nurses,
referred at least 1 young person. Of the 54 referrals, 4 did not
meet inclusion criteria, 3 we were unable to contact, 2 dropped
out of CAMHS before they could consent, and 1 declined to
participate. The remaining 44 completed baseline assessments.
Participants were predominantly girls (40, 91%) with an average
age of 16.0 years (SD=1.4), with 30 (68%) having self-harmed
at least once in the 4 weeks before starting the trial.
Using recommended cut-offs, 42 young people out of 44 (96%)
scored 29 or more on the MFQ, suggesting probable depression.
Using age- and gender-adjusted cut-offs on the RCADS, 37 out
of 44 (84%) screened positive for one or more anxiety disorders
and 37 out of 44 (84%) scored above cut-offs on the SDQ for
a probable emotional disorder. On the RCADS, 16 out of 17
(94%) parents rated their child above the cut-off for depression
and 16 out of 18 parents (89%) scored their child above the
cut-off on the SDQ for significant emotional problems.
Demographic data and baseline psychopathology are
summarized in Tables 1 and 2.
Data summarized in Table 2 indicate that both young people
and parents identified significant problems (young people=85%;
parents=95%), which had been present for longer than 12 months
(young people=85%; parents=95%) and caused significant
distress (young people=78%; parents=100%). The majority of
young people reported significant impairment in friendships
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(80%), ability to learn (76%), leisure activities (73%), and home
life (61%).
Post Familiarization
Postfamiliarization assessments were completed with 40 of the
44 (91%) participants, and of these, 37 (93%) elected to use
BlueIce. Those who did not want to use BlueIce reported that
they were not ready to stop self-harming. Table 3 summarizes
postfamiliarization data.
No safety issues were identified and there were no unintended
negative effects on self-harm. No young person thought that
BlueIce would increase his or her self-harm with 32 out of 40
(80%) strongly endorsing this statement.
In total, 33 out of 40 (83%) thought they would be able to use
BlueIce if they had thoughts of self-harm. Only 2 (5%) felt they
would be unable to do so feeling that their urges to self-harm
would be too powerful to resist. Young people were less sure
about whether BlueIce would help them to stop self-harming,
24 (60%) thought it would, 8 (20%) were unsure, and 6 (15%)
felt it might, with 2 (5%) feeling it would not.
Post Use
Postuse assessments were completed with 33 out of the 37 (89%)
young people, with paired data being available for 30-32 young
people according the specific items analyzed. Data are
summarized in Table 4.
Table 1. Characteristics of participants.
Number of participants, nCharacteristic
Gender
4Male
40Female
Age (years)
112
513
314
915
1516
1117
Self-harm
30Self-harmed at least once in past 4 weeks
14No self-harm in last 4 weeks
Table 2. Young person and parent-rated baseline symptomatology.
Parent reportChild reportMeasure
N/Aa43.6 (9.6)Mood and Feelings Questionnaire, mean (SD)
75.4 (26.9)81.0 (21.9)Revised Child Anxiety and Depression Scale, mean (SD)
23.8 (6.3)21.4 (3.3)Strengths and Difficulties Questionnaire, mean (SD)
17 (95)33 (85)Definite or severe problem, n (%)
17 (95)33 (85)Problem present longer than 12 months, n (%)
18 (100)31 (78)Causes medium to great deal of distress, n (%)
14 (78)23 (61)Effect on home life (medium to great deal), n (%)
16 (89)31 (80)Effect on friendships (medium to great deal), n (%)
11 (61)28 (76)Effect on ability to learn (medium to great deal), n (%)
14 (78)29 (73)Effect on leisure (medium to great deal), n (%)
15 (83)31 (80)Burden on you and family (quite a lot to great deal), n (%)
aN/A: not applicable.
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Table 3. BlueIce post familiarization (2 weeks).
DefinitelyThink soNot sureMaybeNoQuestion
1320322Would you be able to use BlueIce if you had thoughts of self-harm?
004432Do you think BlueIce might make you harm more?
915862Do you think BlueIce would help you to stop harming?
Table 4. Paired baseline and follow-up scores on standardized measures.
SignificanceFollow-up, mean (SD)Baseline, mean (SD)Measure
P valuet (degrees of
freedom)
Self-report (n=30-32)
.042.11 (31)37.84 (15.44)42.75 (10.73)Mood and Feelings Questionnaire (MFQ)
Revised Child Anxiety and Depression Scale (RCADS)
.0072.90 (29)11.20 (6.40)14.00 (7.31)Panic disorder
.012.77 (28)7.37 (4.97)8.90 (4.20)Separation anxiety disorder
.012.72 (29)9.50 (4.05)11.27 (3.50)Generalized anxiety disorder
.0013.58 (29)16.60 (6.33)19.67 (5.65)Social anxiety disorder
.012.64(29)5.70 (4.74)6.97 (4.21)Obsessive compulsive disorder
.022.40 (30)16.58 (6.62)19.16 (5.13)Depression
.0013.76 (29)66.80 (28.46)80.33 (23.75)Total RCADS
Strengths and Difficulties Questionnaire (SDQ)
.540.62 (31)5.22 (1.83)5.44 (1.63)Hyperactivity scale
.0072.90 (31)7.06 (2.17)7.91 (1.51)Emotional symptoms scale
.18−1.36 (31)5.25 (1.61)4.91 (1.55)Peer problems scale
.32−1.01 (31)7.63 (1.56)7.34 (2.24)Prosocial scale
.510.67 (31)2.75 (1.05)2.91 (1.23)Conduct problems scale
.261.16 (31)20.28 (4.47)21.16 (3.35)Total SDQ
Parent-report (n=10-13)
Revised Child Anxiety and Depression Scale (RCADS)
.171.50 (9)12.10 (4.04)13.70 (6.36)Panic disorder
.251.22 (10)9.91 (4.74)10.73 (5.29)Separation anxiety disorder
.111.76 (10)10.00 (2.93)11.55 (4.74)Generalized anxiety disorder
.311.08 (10)17.64 (6.14)18.64 (5.56)Social anxiety disorder
.590.58 (9)9.50 (5.15)9.10 (5.86)Obsessive Compulsive Disorder
.790.27 (10)17.64 (6.35)17.91 (6.49)Depression
.331.03 (9)77.70 (23.21)80.90 (30.49)Total RCADS
Strengths and Difficulties Questionnaire (SDQ)
.690.41 (12)4.15 (1.91)4.31 (1.65)Hyperactivity scale
.032.42 (11)7.25 (2.60)8.17 (2.37)Emotional symptoms scale
.032.50 (12)5.77 (1.79)8.38 (3.82)Peer problems scale
.321.03 (12)6.54 (1.85)7.23 (1.64)Prosocial scale
.490.72 (12)3.23 (1.83)2.92 (1.12)Conduct problems scale
.0014.67 (11)20.50 (6.25)24.58 (6.95)Total SDQ
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Table 5. Self-harm status at baseline and post use.
Number of participants, nSelf-harm status
At baseline
7Not self-harmed in 4 weeks before baseline assessment
26Self-harmed in 4 weeks before baseline assessment
Post use (12-week)
7Not self-harmed at follow-up
0Self-harmed during follow-up
4Not self-harmed during follow-up
15Self-harmed during follow-up at a reduced rate
7Self-harmed during follow-up at same rate
Depression, Anxiety, and Behavior
At follow-up, there was a statistically significant mean difference
of 4.91 (t31=2.11; P=.04; 95% CI 0.17-9.64) on postuse
symptoms of depression (MFQ) and 13.53 on symptoms of
anxiety (RCADS) (t30=3.76; P=.001; 95% CI 6.17-20.90), which
was evident across all anxiety subscales. There was no
statistically significant change on the behavior-screening
questionnaire (SDQ) other than a significant mean difference
of 0.84 on the emotional subscale (t29=2 .90; P=.007; 95% CI
0.25-1.44).
The analysis was repeated comparing those who reported no
change in self-harm (n=7) with those who had not harmed or
did so at a reduced rate (n=26). There were no postuse changes
on any measure for those who self-harmed at the same rate. For
those who had not harmed or did so at a reduced rate, there was
a 7.48 postuse reduction on mean MFQ (95% CI 1.94-13.03;
t24=2.78; P=.01), 16 mean reduction on the RCADS (95% CI
7.63-24.37; t24=3.95, P=.001), and 1.0 mean reduction on the
emotional subscale of the SDQ (95% CI 0.27-1.73, t24=2.81,
P=.01).
A total of 18 parents of younger children completed baseline
measures. Of these, 13 completed postuse questionnaires with
paired data being available for 10-13 parents according to the
specific items analyzed. There were no significant differences
on the parent-completed RCADS. However, on the SDQ, there
was a statistically significant postuse mean difference of 0.92
on the emotional subscale (95% CI 0.083-1.75; t11=2.42; P=.03),
2.61 on the peer relationship subscale (95% CI 0.334-4.90;
t12=2.50; P=.03), and 4.08 on the total score (95% CI 2.16-6.01;
t11=4.67; P=.001).
Numbers were too small to compare parental reported changes
in symptoms for young people who reported changes in
self-harm with those who were self-harming at the same rate.
Acceptability
Finally, postuse ratings on a 10-point scale (higher score=more
positive endorsement) were high for ease of use (8.9, SD=1.2)
and whether they would recommend BlueIce (8.6, SD=1.6) and
slightly lower for helpfulness (6.6, SD=2.2). At the end of the
study, 29 of the 33 interviewed (88%) wanted to keep the app.
Of those who did not want it, 1 no longer felt she needed it, 2
were not ready to stop self-harming, and 1 felt it was too much
of a chore to use.
Self-Harm
Self-report changes in self-harm are summarized in Table 5.
All of those who reported not self-harming in the 4 weeks before
baseline assessment maintained their status and had not
self-harmed over the course of the 12-week trial. Of those 26
who had self-harmed at baseline, 4 (15%) had completely
stopped, with a further 15 (58%) reporting less frequent acts of
self-harm at follow-up. There was a small group of young people
(7, 27%) who reported no reductions in their self-harming
behavior over the 12-week trial.
We calculated the number of self-harm acts prevented in 2 ways.
First, we obtained data on baseline rates of self-harm for the 4
young people who had stopped self-harming at follow-up. We
used this to estimate the number of self-harm events that were
prevented if they continued to self-harm at the same rate, during
the 12-week study. Second, for the 15 who continued to
self-harm but at a reduced rate, we quantified the change to
determine how many episodes BlueIce had prevented. Of the
19 young people who reported reduced self-harm, 10 had a
reduction of 1-5 incidents, 2 a reduction of 6-10 incidents, and
7 a reduction of 11 or more incidents. These calculations suggest
that a total of 308 incidents of self-harm were prevented during
the course of this study.
Finally, feedback from young people at the end of the study
revealed that no one had called the emergency numbers provided
on BlueIce. Similarly, no clinician withdrew any young person
from the study due to an escalation of risk or the emergence of
suicidal planning or a suicide attempt.
Discussion
Principal Findings
Our study group comprised young people with chronic mental
health problems that were significantly impairing most parts of
their everyday life. They reported high levels of symptoms of
depression and anxiety, with over two-thirds self-harming at
least once in the 4 weeks before joining the study. It is therefore
encouraging that a majority of this group found BlueIce to be
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acceptable and were keen to use it after familiarization and
elected to keep it at the end of the study. Similarly, BlueIce
proved acceptable to all core professionals groups working in
CAMHS. Child and adolescent psychiatrists, clinical
psychologist, family therapists, child psychotherapists, nurses,
and occupational therapists all referred young people to the
project. Statistically significant reductions in symptoms of
depression and anxiety over the course of the 12-week trial are
also encouraging.
Codesign
The acceptability of BlueIce was undoubtedly enhanced by the
involvement of young people and clinicians during the design
and development phase. The app was coproduced with young
people who advised on all aspects including design, layout,
flow, and content. Similarly, workshops with clinicians ensured
that the mood-lifting techniques reflected both the recommended
interventions of the National Institute for Health and Care
Excellence and clinical practice. Our experience supports the
recommendation of a recent review that any new therapeutic
intervention should be developed in collaboration with patients
to ensure that it meets their needs [11].
Adverse Effects
mHealth researchers have reported that apps can pose risks to
patient safety and that actions should be taken to mitigate these
risks [26,27]. Given the nature of self-harm and associated
comorbid difficulties, it was necessary to ensure BlueIce worked
as intended and did not make young people’s difficulties worse.
There were no adverse events during the course of the study.
No young person used the emergency contact numbers, none
were withdrawn by their clinician following increased risk, and
young people did not feel that BlueIce would increase their
self-harm. Young people were more cautious when answering
about whether BlueIce would help them to stop self-harming.
Although only a few completely stopped, almost three-quarters
reported that they had stopped or were self-harming at a reduced
rate after using BlueIce. These young people identified a total
of 308 potential episodes of self-harm that were prevented over
a 12-week period. Although the majority of self-harm does not
result in emergency department attendance, it is likely that some
of these episodes would have resulted in contact with primary
or secondary care services. Furthermore, the use of BlueIce may
also reduce the number of face-to-face contacts with mental
health services. This needs to be examined in future studies as
the potential cost savings from this low-cost intervention could
be considerable.
Who Did Not Find BlueIce Helpful
There were a small minority of young people who did not find
BlueIce helpful. The 3 who declined to use BlueIce after
familiarization reported that they did not feel ready to stop
self-harming. Similarly, feedback from those who used BlueIce
suggested that there were times when their distress was too
overwhelming to use the app. Our findings suggest that the
preparedness of young people to stop self-harming needs careful
assessment. Providing BlueIce for young people who are not
motivated or ambivalent to change will not be effective. Second,
young people need to be encouraged to use BlueIce at an earlier
stage in the distress escalation cycle. By earlier use, they may
be able to prevent the distress buildup and self-harm cycle.
However, we are mindful that BlueIce is a smartphone app and
that the limitations of digital support in preventing all self-harm
need to be recognized.
Limitations
Our study is exploratory and as such has a number of limitations.
First, we report a self-selected case series of young people who
actively elected to trial BlueIce. Our group may, therefore, have
been more motivated and prepared to address their self-harm.
Second, this was an open uncontrolled study, and we did not
have a comparison group. We do not know whether the
improvements we report are better or worse than usual care.
Third, BlueIce was provided in addition to usual face-to-face
intervention. Consequently, we do not know whether the
improvements on symptoms of depression, anxiety, and
reduction in self-harm we noted were due to BlueIce or their
face-to-face intervention. A randomized trial comparing
treatment as usual with and without BlueIce is required to
quantify the benefits of adding BlueIce to usual care.
Finally, we assessed self-harm through retrospective self-reports,
which may be subject to recall bias. Although this limitation is
recognized, young people were clearly able to identify changes
in their self-harm during the interview, and they directly
attributed these to the use of BlueIce rather than to the usual
care they had received. Subsequent studies should explore the
use of prospective self-harm diaries and the exploration of
hospital records of A&E attendances following self-harm.
Finally, we are reporting a small exploratory study that is not
sufficiently powered to explore the effects on psychological
functioning or self-harm over time. Although our results are
promising, we need to be cautious about the strength of any
conclusions that can be drawn from our findings. This needs to
be addressed in a subsequent, suitably powered, randomized
controlled trial.
Conclusions
In spite of these limitations, our results are encouraging and
suggest that a smartphone app, used alongside a traditional
CAMHS face-to-face intervention, can help young people
manage their emotional distress and urges to self-harm. BlueIce
proved highly acceptable to young people and clinicians. It was
safe with young people reporting a number of improvements in
their mood and reductions in self-harm after use. Further
research is required to determine the additional benefits of
adding BlueIce to face-to-face care and in quantifying potential
cost savings that may result from fewer emergency department
attendances. However, in the meantime, as an adjunct to usual
face-to-face care, BlueIce appears an acceptable and readily
accessible way of empowering young people to manage their
distress.
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